Free Malaysia Today on MSN
Pfizer completes Metsera acquisition in deal worth up to US$10bil
The biotech firm’s shareholder approval opens the door for the US drugmaker to enter the booming weight loss drug market.
Eli Lilly and Novo Nordisk have agreed to sell their weight loss drugs, Wegovy and Zepbound, through the new TrumpRx ...
Novo Nordisk and Eli Lilly denied weight-loss drug partnership with Mangoceuticals on Thursday, hours after the telehealth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback